Sponsored Content by Illumina, Inc.Reviewed by Louis CastelApr 15 2025
Uncover the future of cancer research with Illumina’s expert guide on targeted sequencing for oncology studies.
This essential resource explores how next-generation sequencing (NGS) enables precise identification of cancer biomarkers, determination of hereditary cancer risks, and streamlined workflows for efficient data analysis. Whether you're a researcher looking for high-throughput solutions or a lab professional aiming to optimize sequencing efficiency, this guide provides step-by-step insights, practical applications, and trusted technological solutions to enhance your oncology studies.
Designed for ease of use and efficiency, our guide highlights the benefits of small oncology panels, including faster turnaround times, cost-effective sequencing, and simplified data analysis. With an intuitive workflow covering library preparation, sequencing, and variant interpretation, you can achieve high-quality results in under 24 hours.
Discover how targeted panels can maximize sample efficiency, reduce technical failures, and empower breakthroughs in cancer research. Download the guide today and take a decisive step toward advancing precision oncology.
CAP number - M-EMEA-01823
For Research Use Only. Not for use in diagnostic procedures (except as specifically noted).
Download the Guide
About Illumina, Inc.
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina's innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.